Text Size
Trial record 5 of 10 for:    Hemifacial Spasm
Previous Study | Return to List | Next Study

Movement Disorder Survey in East China (MDS)

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Sir Run Run Shaw Hospital
ClinicalTrials.gov Identifier:
NCT01168388
First received: July 21, 2010
Last updated: July 20, 2011
Last verified: April 2010
History of Changes
  Purpose

Movement disorder involve recurring or constant muscle contractions causing squeezing or twisting movement, such as hemifacial spasm, blepharospasm, cervical dystonias etc. The most common focal dystonia was cervical dystonia in western countries according to previous studies, which is different from China in Chinese neurologists' opinion. And there is no such survey. So the investigators are conducting a movement disorder survey in east China to confirm it.


Condition
Primary Dystonia
Hemifacial Spasm

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Movement Disorder Survey in East China

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Sir Run Run Shaw Hospital:

Primary Outcome Measures:
  • Number of participants with primary dystonia [ Time Frame: half year ] [ Designated as safety issue: No ]
    It is Cross-Sectional, service-based survey to study the primary dystonina prevalence in east China.


Secondary Outcome Measures:
  • Number of participants with hemifacial spasm [ Time Frame: half year ] [ Designated as safety issue: No ]
    It is a Cross-Sectional survey to study the prevalence of hemifacial spasm in movement disorder of east China.

  • Number of participants with blepharospasm [ Time Frame: half year ] [ Designated as safety issue: No ]
    It is a Cross-Sectional survey to study the prevalence of blepharospasm in movement disorder of east China.


Estimated Enrollment: 1600
Study Start Date: April 2010
Study Completion Date: August 2010
Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Movement disorder

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients seeking treatment in movement disorder clinics in east China during April 2010 to August 2010.

Criteria

Inclusion Criteria:

  • Patients seeking treatment in movement disorder clinics(include naive or may have previously been to clinics)

Exclusion Criteria:

  • Patients who have received this movement disorder survey
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01168388

Locations
China, Zhejiang
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China, 310016
Sponsors and Collaborators
Sir Run Run Shaw Hospital
GlaxoSmithKline
Investigators
Study Chair: Xingyue Hu, MD Sir Run Run Shaw Hospital
  More Information

Publications:

Responsible Party: Xingyue Hu, Sir Run Run Shaw Hospital
ClinicalTrials.gov Identifier: NCT01168388     History of Changes
Other Study ID Numbers: SirRRSH-001
Study First Received: July 21, 2010
Last Updated: July 20, 2011
Health Authority: United States: Food and Drug Administration
China: Food and Drug Administration

Keywords provided by Sir Run Run Shaw Hospital:
Dystonia
Hemifacial spasm
Cervical dystonia
Blepharospasm

Additional relevant MeSH terms:
Spasm
Hemifacial Spasm
Dystonia
Dystonic Disorders
Movement Disorders
Dyskinesias
Neurologic Manifestations
 Nervous System Diseases
Signs and Symptoms
Central Nervous System Diseases
Neuromuscular Manifestations
Mouth Diseases
Stomatognathic Diseases

ClinicalTrials.gov processed this record on May 19, 2013